Sprache: Englisch
Verlag: Berlin, Springer, 1999
Anbieter: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Deutschland
Verbandsmitglied: GIAQ
Paperback. Zustand: Wie neu. 2nd printing. XVII, 248 S.; Ill. Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 510.
gebundene Ausgabe. Zustand: Gut. 248 Seiten Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber und kann entsprechende Merkmale aufweisen (Rückenschild, Instituts-Stempel.). In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 525.
Anbieter: Anybook.com, Lincoln, Vereinigtes Königreich
EUR 24,78
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,600grams, ISBN:9783540650256.
Anbieter: Phatpocket Limited, Waltham Abbey, HERTS, Vereinigtes Königreich
EUR 38,77
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 272 | Sprache: Englisch | Produktart: Bücher | A cover story of Business Week Magazine in January 1984 stated "Biotech Comes of Age". In February 1986, Venture Magazine had a cover article entitled "The Biotech Revolution is Here". This article went on to say "New Genetic Technologies Will Transform Our Lives". These announcements were made many years after the first biotechnology companies, such as Genentech, Cetus, Amgen and Biogen, were formed-to commercialize the "New Biology". . At the time of writing this book, there are over 1300 biotech companies developing new technologies or identifying potential biotech drugs. Most of these companies were started in the height of the "high-technology hype", although companies are still forming as the technology advances. A more recent survey showed only a relatively small number of Food and Drug Administration (FDA) approvals among over several hundred biotech nology products now in clinical trial. One could ask why it has taken so long to produce biotechnology products. Part of the reason is that each new class of biotech products brings with it a set of problems that need to be solved before they enter clinical trials. These problems are often unique to biotechnology products, such as peptides, proteins, monoclonal antibodies, nucleic acids and cellular therapies.
Sprache: Englisch
Verlag: Springer, Springer Vieweg, 1998
ISBN 10: 3540650253 ISBN 13: 9783540650256
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - A cover story of Business Week Magazine in January 1984 stated 'Biotech Comes of Age'. In February 1986, Venture Magazine had a cover article entitled 'The Biotech Revolution is Here'. This article went on to say 'New Genetic Technologies Will Transform Our Lives'. These announcements were made many years after the first biotechnology companies, such as Genentech, Cetus, Amgen and Biogen, were formed-to commercialize the 'New Biology'. . At the time of writing this book, there are over 1300 biotech companies developing new technologies or identifying potential biotech drugs. Most of these companies were started in the height of the 'high-technology hype', although companies are still forming as the technology advances. A more recent survey showed only a relatively small number of Food and Drug Administration (FDA) approvals among over several hundred biotech nology products now in clinical trial. One could ask why it has taken so long to produce biotechnology products. Part of the reason is that each new class of biotech products brings with it a set of problems that need to be solved before they enter clinical trials. These problems are often unique to biotechnology products, such as peptides, proteins, monoclonal antibodies, nucleic acids and cellular therapies.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 1999
ISBN 10: 3540659277 ISBN 13: 9783540659273
Anbieter: moluna, Greven, Deutschland
EUR 336,82
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. * Study Edition of the successful volume 137 in the Handbook of Experimental Pharmacology series * Original edition already sold outWhile addressing the particular problems associated with several classes of biotechnology products, this book also demons.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 404,55
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 440,09
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 248 pages. 9.25x6.25x0.50 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 442,05
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 248 pages. 9.75x6.50x0.75 inches. In Stock.